The Asia Pacific Intragastric Balloon Market would witness market growth of 13.7% CAGR during the forecast period (2020-2026).
Intragastric balloon technological advancements to provide effective treatment are expected to fuel the market growth during the forecast period. Advances in reducing adverse effects such as gastric erosion, ulceration, and vomiting can promote growth in business. For example, novel systems such as Spatz adjustable balloon and ReShape Duo are specifically designed with antimigration properties which prevent migration and allow adjustment of the volume of the balloon. These advancements would accelerate the growth of the intragastric balloon industry over the projected period.
Owing to growing cases of obesity, the Australian intragastric balloon market accounted for a dominant market share in the regional market. More than 60 percent of the Australian population is suffering from obesity, according to the Australia & New Zealand Mental Health Association (ANZMH). A high prevalence of obesity is attributed to following a sedentary lifestyle, thereby propelling growth in the market.
Intragastric balloon surgery in India is one of the most popular procedures for obesity surgery carried out by patients from outside the world. India’s hospitals and health-care services are outstanding in terms of cost and efficiency. This surgery comes with the best medical treatment to gain from weight loss. There are advanced hospitals and the best-trained doctors in India’s medical infrastructure. With the best facilities, high-quality medical services, followed by the most affordable prices, the hospitality and treatment for Intragastric balloon treatment in India fascinate international patients.
Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil
Scope of the Study
Market Segmentation:
By Administration

  • Endoscopy and
  • Pill Form


By Type

  • Single
  • Dual and
  • Triple


By Filling Material

  • Gas Filled and
  • Saline Filled


By End Use

  • Clinics
  • Hospitals and
  • Ambulatory Surgical Centers


By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific


Companies Profiled

  • ? Sientra, Inc. (Silimed, Inc.)
  • ? Apollo Endosurgery, Inc.
  • ? Obalon Therapeutics, Inc.
  • ? ReShape Lifesciences Inc.
  • ? Allurion Technologies, Inc.
  • ? Helioscopie SA (Sante Actions Group)
  • ? Districlass Medical SA
  • ? Spatz FGIA, Inc.
  • ? Duomed Group (Life Partners Europe)
  • ? Medsil


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free